OpenAI launched GPT-5.3-Codex as Anthropic released Claude Opus 4.6 in a simultaneous drop that kicks off the AI coding wars, ...

Learn the exact roadmap to get a software engineering job in 2026, from choosing the right tech stack to building real projects and preparing for interviews. This video breaks down the best skills to ...

Recent Exact Sciences Corporation financials show accelerating revenue growth and stable margins, despite ongoing investments in screening and MRD. While EXAS maintains leadership in stool-based CRC ...

Abstract: Exact analytical solutions of canonical electromagnetic scattering problems that have been developed in the last 30 years are reviewed to emphasize that many geometrical shapes exist for the ...

Abbott Laboratories ABT-0.83%decrease; red down pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS-0.16%decrease; red down pointing triangle in a deal valued at about ...

Abbott is acquiring Exact Sciences for $23 billion, the global healthcare leader announced on Thursday. Exact Sciences shareholders will receive $105 per common share, totaling approximately $21 ...

Abbott has agreed to acquire cancer test-maker Exact Sciences for about $21 billion. Exact Sciences makes the Cologuard noninvasive screening test for colorectal cancer. The company also makes tests ...

Exact Sciences (EXAS) will likely need to see over $100 a share in a takeover, according to a William Blair analyst, after an earlier report that Abbott Labs (ABT) is in talks to buy the cancer test ...

Nov 19 (Reuters) - Medical device maker Abbott Laboratories (ABT.N), opens new tab is nearing a potential takeover of cancer test maker Exact Sciences Corp (EXAS.O), opens new tab, Bloomberg News ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $851 million for ...